Kane Biotech presents revyve clinical and health-economic data at SAWC Fall 2026

PUBT · 1d ago
Kane Biotech presents revyve clinical and health-economic data at SAWC Fall 2026
  • Kane Biotech will present clinical and health-economic findings on revyve at SAWC Fall 2026 on Oct. 17 in Las Vegas.
  • Results have not yet been presented; three posters are scheduled for the conference session running 6:15 p.m. to 7:30 p.m. PDT.
  • Posters indicate revyve may help shift chronic wounds toward healing, support standard wound-care use, and align tissue oxygenation changes with wound reduction.
  • The company will use the meeting to market the revyve line to clinicians, support distributors, and pursue expanded US commercialization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kane Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070705PRIMZONEFULLFEED9841175) on October 07, 2026, and is solely responsible for the information contained therein.